CN103646745B - 一种负载贵金属量子点的磁性复合微球及其制备方法 - Google Patents
一种负载贵金属量子点的磁性复合微球及其制备方法 Download PDFInfo
- Publication number
- CN103646745B CN103646745B CN201310687186.8A CN201310687186A CN103646745B CN 103646745 B CN103646745 B CN 103646745B CN 201310687186 A CN201310687186 A CN 201310687186A CN 103646745 B CN103646745 B CN 103646745B
- Authority
- CN
- China
- Prior art keywords
- noble metal
- quantum dot
- magnetic
- microsphere
- polymer microsphere
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000005291 magnetic effect Effects 0.000 title claims abstract description 82
- 239000004005 microsphere Substances 0.000 title claims abstract description 74
- 239000002096 quantum dot Substances 0.000 title claims abstract description 58
- 229910000510 noble metal Inorganic materials 0.000 title claims abstract description 57
- 239000002131 composite material Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 229920000642 polymer Polymers 0.000 claims abstract description 46
- 238000006243 chemical reaction Methods 0.000 claims abstract description 5
- 239000000839 emulsion Substances 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 9
- 229910021641 deionized water Inorganic materials 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical group C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 5
- 239000011976 maleic acid Substances 0.000 claims description 5
- 229910052763 palladium Inorganic materials 0.000 claims description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 5
- 239000012279 sodium borohydride Substances 0.000 claims description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000005642 Oleic acid Substances 0.000 claims description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical group [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 claims description 3
- 235000019394 potassium persulphate Nutrition 0.000 claims description 3
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 claims description 2
- 238000000975 co-precipitation Methods 0.000 claims description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 3
- 238000000015 thermotherapy Methods 0.000 abstract description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229910052814 silicon oxide Inorganic materials 0.000 description 2
- ZPZDIFSPRVHGIF-UHFFFAOYSA-N 3-aminopropylsilicon Chemical compound NCCC[Si] ZPZDIFSPRVHGIF-UHFFFAOYSA-N 0.000 description 1
- 229910004613 CdTe Inorganic materials 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910001566 austenite Inorganic materials 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 238000000593 microemulsion method Methods 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000005476 size effect Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000001931 thermography Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/42—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of organic or organo-metallic materials, e.g. graphene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
- C08F212/02—Monomers containing only one unsaturated aliphatic radical
- C08F212/04—Monomers containing only one unsaturated aliphatic radical containing one ring
- C08F212/06—Hydrocarbons
- C08F212/08—Styrene
Landscapes
- Engineering & Computer Science (AREA)
- Power Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Hard Magnetic Materials (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Abstract
本发明公开了一种负载贵金属量子点的磁性复合微球及其制备方法,其包括磁性聚合物微球和负载在该磁性聚合物微球表面的贵金属量子点。本发明的磁性复合微球以磁性聚合物微球为载体,在表面负载贵金属量子点,具优异的磁学性能,可以通过外部磁场的作用控制其移动方向;处在红外区域吸收的微球可以有效的实现光—热之间的转换,在肿瘤热疗等领域的应用前景广阔。
Description
技术领域
本发明属于复合材料技术领域,具体涉及一种负载贵金属量子点的磁性复合微球及其制备方法。
背景技术
近年来,贵金属量子点因其优异特性吸引了广大研究人员的兴趣。量子点是指半径小于或接近激光波尔半径的纳米晶,是一类不同于本体又异于分子、原子特性的新型材料,具有独特的量子尺寸效应和表面增强效应。与传统的有机染料相比,量子点的吸收光谱取决于其粒径以及量子点之间的距离,覆盖从紫外到红外区域,光谱特征优异、光化学性质稳定,在免疫检测、细胞及活体成像、基因分析和肿瘤热疗等领域具有很好的应用。
磁性微球是一类极具应用前景的功能材料,它除了一般纳米材料所具备的特性外,还呈现出不同与传统磁性材料的新特性,如超顺磁性、低居里温度和高磁化率等。通过将目标分子或目标细胞通过功能基团吸附在磁性微球上,在外部磁场作用下可以实现蛋白质提纯、核酸分离和药物靶向释放等。
将量子点和磁性微球结合在一起,得到一种既具有量子点光学效应,又兼具磁性能的复合微球,具有诱人的应用前景。在这一领域,Wang等(D.Wang,J.He,N.Rosenzweigetal,Nano.Lett.,2004,4,409-412.)将CdSe/ZnS量子点直接通过巯基吸附在聚合物包裹的γ-Fe2O3表面,并将其用于癌细胞的荧光检测和磁分离。Salgueirino等(V.Salgueirino-Maceira,M.A.Correa-Duarte,etal,Adv.Funct.Mater.,2006,16,509-514.)首先采用stober法制备了一种磁性二氧化硅小球,其次利用层层自组装技术在二氧化硅小球的外面吸附一层聚电解质和CdTe量子点,最后再包裹上一层二氧化硅得到一种发冷光的复合微球。这种方法微球的磁含量较低且无法调控,具有一定的局限性。Kim等(J.Kim,S.Park,etal,Angew.Chem.Int.Ed.,2006,45,7754-7758.)报道了一种兼具磁共振成像和热成像功能的复合微球。这种复合微球以氨基功能化的二氧化硅小球为基体,表面负载了溴代异丁酸稳定的Fe3O4纳米粒子和纳米贵金属,通过外部光强的控制可以有效的杀死癌细胞。其缺点是制备工艺复杂,且以二氧化硅为基体无法在碱性环境中稳定存在,应用受到一定的限制。贺蓉等(荧光磁性多功能纳米材料的制备方法,中国专利,公开号CN1831079A)利用氨硅烷偶联剂修饰Fe3O4表面,再通过氨基和羧基之间的静电作用,将量子点直接组装在Fe3O4粒子表面。这种方法量子点的吸附量难以控制,且两种粒子由于直接接触导致荧光强度急剧下降。
目前,以磁含量可控的具有核-壳结构的磁性聚合物为载体,兼具可调光学和磁学性能的复合微球尚未见报道。
发明内容
本发明的目的在于克服现有技术缺陷,提供一种负载贵金属量子点的磁性复合微球。
本发明的另一目的在于提供上述负载贵金属量子点的磁性复合微球的制备方法。
本发明的技术方案如下:
一种负载贵金属量子点的磁性复合微球,包括磁性聚合物微球和负载在该磁性聚合物微球表面的贵金属量子点。
在本发明的一个优选实施方案中,所述磁性聚合物微球包括一核心和一外壳,所述核心为一内包磁性四氧化三铁的聚苯乙烯球,所述外壳为聚马来酸异醇双酯。
在本发明的一个优选实施方案中,所述贵金属为金、银、铂和钯中的一种。
本发明的另一技术方案如下:
一种上述负载贵金属量子点的磁性复合微球的制备方法,包括如下步骤:
(1)制备磁性聚合物微球;
(2)将贵金属量子点负载在上述磁性聚合物微球上;
(3)根据需要控制贵金属量子点的尺寸和形状。
在本发明的一个优选实施方案中,所述步骤(1)为将马来酸异醇双酯溶于去离子水中,搅拌1~2小时后加入Fe3O4、苯乙烯单体继续搅拌6~12小时后加入引发剂升温至60~65℃反应12~24小时即得到磁性聚合物微球乳液。
进一步优选的,所述马来酸异醇双酯、Fe3O4和苯乙烯单体的含量分别为0.1%~1wt%、0.5%~5wt%和2%~10wt%,余量为去离子水;所述引发剂为水溶性引发剂,其用量为苯乙烯单体的0.1%~1wt%;所述Fe3O4采用化学共沉淀法制备,并利用油酸加以改性,油酸与Fe3O4的质量比为1:1.05~1:1.15。
进一步优选的,所述引发剂为过硫酸钾或过硫酸铵。
在本发明的一个优选实施方案中,所述步骤(2)为取所述磁性聚合物微球乳液,加入贵金属酸化物水溶液搅拌1~3小时后加入硼氢化钠水溶液继续搅拌2~6小时即得到负载贵金属量子点的磁性聚合物微球。
进一步优选的,所述贵金属酸化物为氯金酸、硝酸银、氯铂酸、氯钯酸中的一种,加入量占磁性聚合物微球乳液的0.1%~1wt%;硼氢化钠的加入量占磁性聚合物微球乳液的0.5%~5wt%。
在本发明的一个优选实施方案中,所述步骤(3)为将步骤(2)中负载贵金属量子点的磁性聚合物微球乳液离心分离除去游离在水中的贵金属量子点,然后重新分散在去离子水中,加入同种贵金属酸化物水溶液搅拌0.5~2小时后加入抗坏血酸水溶液继续搅拌2~4小时即可实现负载在磁性聚合物微球表面贵金属量子点的生长、量子点的尺寸和形状发生改变。
进一步优选的,所述同种贵金属酸化物的加入量占聚合物微球乳液的0.5%~3wt%;抗坏血酸的加入量占聚合物微球乳液的0.5%~3wt%。
本发明的有益效果是:
1、本发明的磁性复合微球以磁性聚合物微球为载体,在表面负载贵金属量子点,具优异的磁学性能,可以通过外部磁场的作用控制其移动方向;处在红外区域吸收的微球可以有效的实现光—热之间的转换,在肿瘤热疗等领域的应用前景广阔;
2、本发明的其制备方法采用微乳液法一步合成磁性聚合物微球,包含Fe3O4、聚苯乙烯核层和马来酸酯壳层三部分。通过在磁性聚合物微球表面直接还原贵金属盐负载量子点并调控量子点的生长得到在不同光波区域均有吸收的复合微球。其光学和磁学双重性能有望在生物医疗等领域得到重要的应用。
附图说明
图1为本发明的实施例1中磁性聚合物微球的TEM图。
图2为本发明的实施例1中步骤(2)制备的负载贵金属量子点的磁性复合微球的TEM图;
图3为本发明的实施例1中步骤(3)制备的负载贵金属量子点的磁性复合微球的TEM图;
图4为本发明的实施例1制备的负载贵金属量子点的磁性复合微球的磁滞回线图。
图5为本发明的实施例2~4制备的负载贵金属量子点的磁性复合微球的UV-vis吸收光谱,参照组为负载贵金属量子点的磁性聚合物微球。
具体实施方式
以下通过具体实施方式结合附图对本发明的技术方案进行进一步的说明和描述。
实施例1
(1)磁性聚合物微球的制备
40mg马来酸异醇双酯溶于40mL去离子水中,机械搅拌2小时,加入0.5gFe3O4、3g苯乙烯单体,通氮气,继续搅拌12小时后加入30mg过硫酸钾升温至65℃反应24小时得到具有核壳结构的磁性聚合物微球乳液。通过透射电镜(TEM)对所得微球进行结构表征,如图1,磁性聚合物微球的整体尺寸为250nm左右,其中核层尺寸为150nm左右,壳层厚度为50nm左右;Fe3O4包含在微球内部,尺寸为8nm左右。
(2)贵金属量子点的负载
取1mL步骤(1)中磁性聚合物微球乳液用去离子水稀释至10mL;搅拌下逐滴滴加1mL浓度为10mmol/L的氯金酸水溶液;2小时后加入1mL浓度为20mmol/L的硼氢化钠水溶液,常温搅拌6小时后即得到负载贵金属量子点的磁性聚合物微球。通过透射电镜(TEM)对所得微球进行结构表征,如图2所示,贵金属量子点均匀负载在磁性聚合物微球表面;磁性能由SQUID超导量子干涉磁强计进行表征,剩余磁化强度和矫顽力均接近于0,几乎无磁滞存在,具有超顺磁性。
(3)贵金属量子点的生长
将步骤(2)中负载贵金属量子点的磁性聚合物微球乳液离心分离除去游离在水中的贵金属量子点,然后重新分散在10mL去离子水中;加入2.0mL浓度为10mmol/L的氯金酸水溶液,搅拌1小时后加入2.5mL浓度为10mmol/L的抗坏血酸水溶液继续搅拌3小时即可实现负载在磁性聚合物微球表面贵金属量子点的生长,量子点的尺寸和形状发生改变。通过透射电镜(TEM)对所得微球进行结构表征,如图3所示,经过再生长过程的贵金属量子点尺寸和形状发生明显的变化。如图4所示,复合微球的紫外-可见吸收光谱由UnicoUV-vis2802PCS进行表征,随着贵金属量子点的生长,吸收波长发生明显的红移至800左右nm。
实施例2~4
同实施例1工艺,改变步骤(3)中氯金酸水溶液的加入量依次为0.5mL、1.0mL、1.5mL,UV-vis的吸收波长依次为530nm、560nm、690nm,如图5所示。
实施例5~7
同实施例1工艺,改变步骤(2)中贵金属酸化物种类分别为硝酸银、氯铂酸、氯钯酸,得到不同类型的复合微球,结果如下表所示:
以上所述,仅为本发明的较佳实施例而已,故不能依此限定本发明实施的范围,即依本发明专利范围及说明书内容所作的等效变化与修饰,皆应仍属本发明涵盖的范围内。
Claims (5)
1.一种负载贵金属量子点的磁性复合微球的制备方法,该磁性复合微球包括磁性聚合物微球和负载在该磁性聚合物微球表面的贵金属量子点,该磁性聚合物微球包括一核心和一外壳,所述核心为一内包磁性四氧化三铁的聚苯乙烯球,所述外壳为聚马来酸异醇双酯,所述贵金属为金、银、铂和钯中的一种,其特征在于:包括如下步骤:
(1)制备磁性聚合物微球:将马来酸异醇双酯溶于去离子水中,搅拌1~2小时后加入Fe3O4、苯乙烯单体继续搅拌6~12小时后加入引发剂升温至60~65℃反应12~24小时即得到磁性聚合物微球乳液;
(2)将贵金属量子点负载在上述磁性聚合物微球上:取所述磁性聚合物微球乳液,加入贵金属酸化物水溶液搅拌1~3小时后加入硼氢化钠水溶液继续搅拌2~6小时即得到负载贵金属量子点的磁性聚合物微球;
(3)根据需要控制贵金属量子点的尺寸和形状:将步骤(2)中负载贵金属量子点的磁性聚合物微球乳液离心分离除去游离在水中的贵金属量子点,然后重新分散在去离子水中,加入同种贵金属酸化物水溶液搅拌0.5~2小时后加入抗坏血酸水溶液继续搅拌2~4小时即可实现负载在磁性聚合物微球表面贵金属量子点的生长、量子点的尺寸和形状发生改变。
2.如权利要求1所述的一种负载贵金属量子点的磁性复合微球的制备方法,其特征在于:所述马来酸异醇双酯、Fe3O4和苯乙烯单体的含量分别为0.1%~1wt%、0.5%~5wt%和2%~10wt%,余量为去离子水;所述引发剂为水溶性引发剂,其用量为苯乙烯单体的0.1%~1wt%;所述Fe3O4采用化学共沉淀法制备,并利用油酸加以改性,油酸与Fe3O4的质量比为1:1.05~1:1.15。
3.如权利要求2所述的一种负载贵金属量子点的磁性复合微球的制备方法,其特征在于:所述引发剂为过硫酸钾或过硫酸铵。
4.如权利要求1所述的一种负载贵金属量子点的磁性复合微球的制备方法,其特征在于:所述贵金属酸化物为氯金酸、硝酸银、氯铂酸、氯钯酸中的一种,加入量占磁性聚合物微球乳液的0.1%~1wt%;硼氢化钠的加入量占磁性聚合物微球乳液的0.5%~5wt%。
5.如权利要求1所述的一种负载贵金属量子点的磁性复合微球的制备方法,其特征在于:所述同种贵金属酸化物的加入量占聚合物微球乳液的0.5%~3wt%;抗坏血酸的加入量占聚合物微球乳液的0.5%~3wt%。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310687186.8A CN103646745B (zh) | 2013-12-16 | 2013-12-16 | 一种负载贵金属量子点的磁性复合微球及其制备方法 |
PCT/CN2014/093039 WO2015090145A1 (zh) | 2013-12-16 | 2014-12-04 | 一种负载贵金属量子点的磁性复合微球及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310687186.8A CN103646745B (zh) | 2013-12-16 | 2013-12-16 | 一种负载贵金属量子点的磁性复合微球及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103646745A CN103646745A (zh) | 2014-03-19 |
CN103646745B true CN103646745B (zh) | 2016-04-06 |
Family
ID=50251945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310687186.8A Expired - Fee Related CN103646745B (zh) | 2013-12-16 | 2013-12-16 | 一种负载贵金属量子点的磁性复合微球及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103646745B (zh) |
WO (1) | WO2015090145A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103646745B (zh) * | 2013-12-16 | 2016-04-06 | 厦门大学 | 一种负载贵金属量子点的磁性复合微球及其制备方法 |
CN106475022B (zh) * | 2015-09-02 | 2019-09-27 | 南京理工大学 | 一种活性抗菌微球及其制备方法 |
CN106732549B (zh) * | 2016-12-02 | 2019-07-26 | 浙江工业大学 | 一种多孔炭载复合材料催化剂及其制备方法与应用 |
CN108539031B (zh) * | 2018-04-12 | 2020-03-27 | 京东方科技集团股份有限公司 | 量子点成膜方法、显示面板及其制作方法、显示装置 |
CN112121862A (zh) * | 2020-10-15 | 2020-12-25 | 江西赣江新区有机硅创新研究院有限公司 | 磁性固载型铂催化剂及其制备方法与应用 |
CN112516930B (zh) * | 2020-11-16 | 2022-04-29 | 中国工程物理研究院激光聚变研究中心 | 一种制备高球形度、高表面光洁度、高降解性能空心微球的方法 |
CN112973650B (zh) * | 2021-02-08 | 2022-02-08 | 厦门大学 | 一种纳微复合球及其制备方法和应用 |
CN115305463B (zh) * | 2022-07-22 | 2023-08-22 | 东南大学 | 一种复合微球的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102814199A (zh) * | 2012-06-18 | 2012-12-12 | 北京科技大学 | 用于贵金属催化剂原位固载的磁性聚合物微球的制备方法 |
CN103143394A (zh) * | 2013-02-04 | 2013-06-12 | 厦门大学 | 一种纳米贵金属@磁性聚合物复合微球及其制备方法 |
CN103143042A (zh) * | 2013-02-04 | 2013-06-12 | 厦门大学 | 一种超顺磁聚合物微球磁共振成像对比剂及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181687B (zh) * | 2007-12-18 | 2010-08-04 | 吉林大学 | Ag-Fe3O4磁性纳米催化剂及在苯乙烯环氧化中的应用 |
WO2009126649A2 (en) * | 2008-04-07 | 2009-10-15 | Life Bioscience, Inc. | Method of providing particles having biological-binding areas for biological applications |
CN103646745B (zh) * | 2013-12-16 | 2016-04-06 | 厦门大学 | 一种负载贵金属量子点的磁性复合微球及其制备方法 |
-
2013
- 2013-12-16 CN CN201310687186.8A patent/CN103646745B/zh not_active Expired - Fee Related
-
2014
- 2014-12-04 WO PCT/CN2014/093039 patent/WO2015090145A1/zh active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102814199A (zh) * | 2012-06-18 | 2012-12-12 | 北京科技大学 | 用于贵金属催化剂原位固载的磁性聚合物微球的制备方法 |
CN103143394A (zh) * | 2013-02-04 | 2013-06-12 | 厦门大学 | 一种纳米贵金属@磁性聚合物复合微球及其制备方法 |
CN103143042A (zh) * | 2013-02-04 | 2013-06-12 | 厦门大学 | 一种超顺磁聚合物微球磁共振成像对比剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103646745A (zh) | 2014-03-19 |
WO2015090145A1 (zh) | 2015-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103646745B (zh) | 一种负载贵金属量子点的磁性复合微球及其制备方法 | |
Singh et al. | Core–shell nanostructures: a simplest two-component system with enhanced properties and multiple applications | |
Zhang et al. | Exploring heterostructured upconversion nanoparticles: from rational engineering to diverse applications | |
Purbia et al. | Yolk/shell nanoparticles: classifications, synthesis, properties, and applications | |
US20190079014A1 (en) | Core-shell plasmonic nanogapped nanostructured material | |
Chen et al. | Current advances in lanthanide‐doped upconversion nanostructures for detection and bioapplication | |
Chen et al. | Gold nanorods and their plasmonic properties | |
Wang et al. | Facile synthesis of superparamagnetic fluorescent Fe3O4/ZnS hollow nanospheres | |
Wei et al. | Surfactant-assisted cooperative self-assembly of nanoparticles into active nanostructures | |
Wang et al. | Superparamagnetic Fe2O3 beads− CdSe/ZnS quantum dots core− shell nanocomposite particles for cell separation | |
Lv et al. | Hollow Structured Y2O3: Yb/Er–Cu x S Nanospheres with Controllable Size for Simultaneous Chemo/Photothermal Therapy and Bioimaging | |
Qian et al. | Gold decorated NaYF 4: Yb, Er/NaYF 4/silica (core/shell/shell) upconversion nanoparticles for photothermal destruction of BE (2)-C neuroblastoma cells | |
Bao et al. | One-pot synthesis of noble metal/zinc oxide composites with controllable morphology and high catalytic performance | |
Zhai et al. | Fabrication of iron oxide core/gold shell submicrometer spheres with nanoscale surface roughness for efficient surface-enhanced Raman scattering | |
Li et al. | Self-assembly of colloidal inorganic nanocrystals: nanoscale forces, emergent properties and applications | |
Song et al. | Shell-dependent evolution of optical and magnetic properties of Co@ Au core–shell nanoparticles | |
Li et al. | Doxorubicin‐Conjugated Mesoporous Magnetic Colloidal Nanocrystal Clusters Stabilized by Polysaccharide as a Smart Anticancer Drug Vehicle | |
Chen et al. | Preparation and near-infrared photothermal conversion property of cesium tungsten oxide nanoparticles | |
CN101348713A (zh) | 能发射荧光的磁性复合纳米微球及其制备方法 | |
Riva et al. | Plasmonic/magnetic nanocomposites: Gold nanorods-functionalized silica coated magnetic nanoparticles | |
CN103571493B (zh) | 聚苯胺磁性微球连接荧光量子点制备磁性荧光双功能微球 | |
Yeap et al. | Colloidal stability and magnetophoresis of gold-coated iron oxide nanorods in biological media | |
Yin et al. | Multifunctional Fe3O4 cluster@ quantum dot-embedded mesoporous SiO2 nanoplatform probe for cancer cell fluorescence-labelling detection and photothermal therapy | |
Fodjo et al. | Selective synthesis of Fe 3 O 4 Au x Ag y nanomaterials and their potential applications in catalysis and nanomedicine | |
Xia et al. | Luminescent and magnetic α-Fe2O3@ Y2O3: Eu3+ bifunctional hollow microspheres for drug delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160406 |